MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  
HCP Resources  Psychiatry  

Patient Resources 
Bipolar  
Schizophrenia  


Useful Websites

specialistinfo.com
details of 26,000 UK specialists

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

DoctorOnline
information for doctors

The Converter Site
metric and imperial conversion tool.
home > drug information > Clarinex

Clarinex


Company: Schering-Plough
Approval Status: Approved February 2002
Treatment for: Allergic rhinitis; Chronic ideopathic urticaria
Areas: Immunology/Infectious Diseases; Pulmonary/Respiratory Diseases

| General Information | Clinical Results | Side Effects | Mechanism of Action | Additional Information |


General Information

Other Useful Resources
Clarinex, in an oral tablet formulation, was approved for the treatment of seasonal allergic rhinitis (SAR)in adults and children over 12 years of age in December 2001. In February 2002, Clarinex tablets were additionally approved for the treatment of perennial allergic rhinitis (PAR) and for symptomatic relief of chronic idiopathic urticaria (CIU) in adults and children over 12 years old. Clarinex is a once-daily non-sedating antihistamine that provides 24 hour relief.

An estimated 45 million Americans are affected by allergies. Allergic rhinitis (AR) is the most common allergic disorder in the United States, affecting up to 30% of the population.SAR is considered a response to outdoor allergens, while PAR pertains to indoor allergens. AR symptoms impact daily functioning at work, school and during leisure time, resulting in millions of absentee days each year.

Urticaria, known commonly as hives, affects an estimated 20% of Americans at some point in their lives. The condition results from a reaction to a substance, most commonly food, drugs or a topical agent. Urticaria is characterized by itchy, swollen welts on the skin.

< back to top

Clinical Results

Approval of Clarinex for AR treatment is supported by four double-blind, placebo-controlled studies that enrolled over 2,300 SAR sufferersand two double-blind, placebo-controlled trials with over 1,000 subjects with PAR Results show that a single 5 mg dose of Clarinex provides 24 hours of relief from nasal and non-nasal SAR symptoms. During trials, Clarinex provided significantly greater relief than placebo.

Approval for CIU is based on two double-blind, placebo-controlled studies involving 416 subjects. Treatment with Clarinex significantly reduced the severity of pruritis when compared to placebo. Clarinex also performed superior to placebo at reducing the number and size of hives.

< back to top

Side Effects

Adverse events associated with the use of Clarinex may include (but are not limited to) the following:
  • Pharyngitis
  • Dry mouth
  • Nausea
  • Dizziness
  • Somnolence
  • Fatigue
  • Myalgia

< back to top

Mechanism of Action

Clarinex (desloratadine) is a long-acting tricyclic histamine antagonist with selective H-1 receptor histamine antagonist activity that offers clinically proven benefits for the management of AR and CIU.

< back to top

Additional Information

For additional information on Clarinex, please visit Schering-Plough.

< back to top



The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.




medilexicon toolbar

download button

Features:

 Medical Dictionary Searches
 ICD9 Searches
 Other Medical Searches
 Search Word Highlighter
 Medical News Articles
 Latest News Headlines

Medical Toolbar

FREE

Download the Medilexicon Medical Search Toolbar on to your internet browser quickly and easily at the touch of a button.

The toolbar will always appear at the top of your internet browser and will allow you to perform many useful features...

>> Click here for more information about the toolbar <<

toolbar



add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<



Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, Mexico Office: + 52 1998 2142733
© 2007 MediLexicon International Ltd. MediLexicon International Ltd